Literature DB >> 19242508

Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors.

Xue-Song Wu1, Anke S Lonsdorf, Sam T Hwang.   

Abstract

Chemokine receptors are G-protein-coupled, seven-transmembrane-spanning surface receptors that play key roles in cell trafficking, cell motility, and survival. These receptors are activated by small molecular weight chemotactic cytokines called chemokines. Chemokine receptors play roles in the migration and localization of normal T cells (and other leukocytes) during physiological responses in inflamed or infected skin. In cancer cells, these receptors may also facilitate tumorigenesis, metastasis, and resistance to immune-mediated killing. This review will focus on recent data that reveal potential roles of specific chemokine receptors, including CCR4, CXCR4, and CCR10, in the pathophysiology of cutaneous T-cell lymphoma, including mycosis fungoides and Sézary syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242508      PMCID: PMC2669838          DOI: 10.1038/jid.2009.45

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  36 in total

1.  Psoriasis: the plot thickens....

Authors:  M P Schön; T Ruzicka
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Increased CCR4 expression in cutaneous T cell lymphoma.

Authors:  Katalin Ferenczi; Robert C Fuhlbrigge; JackL Pinkus; Geraldine S Pinkus; Thomas S Kupper
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

3.  CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.

Authors:  Bernhard Homey; Harri Alenius; Anja Müller; Hortensia Soto; Edward P Bowman; Wei Yuan; Leslie McEvoy; Antti I Lauerma; Till Assmann; Erich Bünemann; Maili Lehto; Henrik Wolff; David Yen; Heather Marxhausen; Wayne To; Jonathon Sedgwick; Thomas Ruzicka; Percy Lehmann; Albert Zlotnik
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

4.  The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.

Authors:  D Lu; M Duvic; L J Medeiros; R Luthra; D M Dorfman; D Jones
Journal:  Am J Clin Pathol       Date:  2001-03       Impact factor: 2.493

Review 5.  Cutaneous T cell lymphoma: the helping hand of dendritic cells.

Authors:  R L Edelson
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

Review 6.  Role of the CC chemokine receptor 9/TECK interaction in apoptosis.

Authors:  B-S Youn; K-Y Yu; J Oh; J Lee; T-H Lee; H E Broxmeyer
Journal:  Apoptosis       Date:  2002-06       Impact factor: 4.677

7.  Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells.

Authors:  M Wu; H Fang; S T Hwang
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

8.  Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.

Authors:  H Hasegawa; T Nomura; M Kohno; N Tateishi; Y Suzuki; N Maeda; R Fujisawa; O Yoshie; S Fujita
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

9.  CCR7 signaling inhibits T cell proliferation.

Authors:  Ekkehard Ziegler; Martin Oberbarnscheidt; Silvia Bulfone-Paus; Reinhold Förster; Ulrich Kunzendorf; Stefan Krautwald
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

10.  CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.

Authors:  Y Reiss; A E Proudfoot; C A Power; J J Campbell; E C Butcher
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

View more
  19 in total

Review 1.  Tissue-specific homing of immune cells in malignant skin tumors.

Authors:  Hajnalka Jókai; Márta Marschalkó; Judit Csomor; József Szakonyi; Orsolya Kontár; Gábor Barna; Sarolta Kárpáti; Péter Holló
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

Review 2.  NFκB function and regulation in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

3.  Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Ivan V Litvinov; Yang Wang; Lixin Xia; Andreas Willerslev-Olsen; Sergei B Koralov; Katharina L Kopp; Charlotte M Bonefeld; Mariusz A Wasik; Carsten Geisler; Anders Woetmann; Youwen Zhou; Denis Sasseville; Niels Odum
Journal:  Blood       Date:  2013-06-25       Impact factor: 22.113

4.  Retinoids Bias Integrin Expression and Function in Cutaneous T-Cell Lymphoma.

Authors:  Lei Wang; Sebastian S DeMarco; JianMing Chen; Charles M Phillips; Lance C Bridges
Journal:  J Invest Dermatol       Date:  2015-05-07       Impact factor: 8.551

5.  Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.

Authors:  Ido D Weiss; Orit Jacobson; Dale O Kiesewetter; John P Jacobus; Lawrence P Szajek; Xiaoyuan Chen; Joshua M Farber
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

6.  Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Authors:  Tzu-Pei Chang; Vladimir Poltoratsky; Ivana Vancurova
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

7.  Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.

Authors:  Pedro Horna; Lynn C Moscinski; Lubomir Sokol; Haipeng Shao
Journal:  Cytometry B Clin Cytom       Date:  2018-10-16       Impact factor: 3.058

8.  RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell lines.

Authors:  Lei Wang; Sebastian S DeMarco; Mary Stuart Peaks; Abigail L Maiorana-Boutilier; JianMing Chen; Miranda J Crouch; Brian M Shewchuk; Saame Raza Shaikh; Charles M Phillips; Lance C Bridges
Journal:  Exp Dermatol       Date:  2017-07-03       Impact factor: 3.960

9.  Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells.

Authors:  De-Kuan Chang; Jianhua Sui; Shusheng Geng; Asli Muvaffak; Mei Bai; Robert C Fuhlbrigge; Agnes Lo; Anuradha Yammanuru; Luke Hubbard; Jared Sheehan; James J Campbell; Quan Zhu; Thomas S Kupper; Wayne A Marasco
Journal:  Mol Cancer Ther       Date:  2012-08-06       Impact factor: 6.261

10.  Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.

Authors:  Linghua Wang; Xiao Ni; Kyle R Covington; Betty Y Yang; Jessica Shiu; Xiang Zhang; Liu Xi; Qingchang Meng; Timothy Langridge; Jennifer Drummond; Lawrence A Donehower; Harshavardhan Doddapaneni; Donna M Muzny; Richard A Gibbs; David A Wheeler; Madeleine Duvic
Journal:  Nat Genet       Date:  2015-11-09       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.